Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
About Definitive Healthcare Corp. (DH)
Definitive Healthcare Corp. (Nasdaq: DH) is a leading provider of healthcare commercial intelligence, delivering actionable data and insights to organizations across the healthcare ecosystem. The company's mission is to transform data, analytics, and expertise into meaningful intelligence that enables its clients to uncover opportunities, optimize strategies, and drive growth. By leveraging a robust SaaS-based platform, Definitive Healthcare empowers clients to navigate the complexities of the healthcare market with precision and confidence.
Comprehensive Data and Analytics Platform
At the core of Definitive Healthcare's offerings is its proprietary platform, which aggregates and analyzes data on over 8,100 hospitals, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 accountable care organizations (ACOs) and health information exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals. This extensive dataset provides clients with unparalleled visibility into the healthcare provider landscape, enabling them to make informed decisions in areas such as market segmentation, sales execution, and product development.
Key Solutions and Products
- Monocl ExpertInsight: A comprehensive tool that delivers data on more than 15 million medical experts globally, helping pharmaceutical and medtech companies enhance Key Opinion Leader (KOL) engagement and clinical collaboration.
- Population Intelligence: Combines clinical and consumer data to enable precision marketing, allowing businesses to identify and target specific audience segments effectively.
- Carevoyance: A solution tailored for medtech sales teams, providing deep insights into provider segmentation, territory alignment, and sales tracking to streamline workflows and accelerate device adoption.
- Market Forecast: A predictive analytics tool that offers three, five, and ten-year market trend projections, helping healthcare organizations plan strategically for future demand and growth opportunities.
- DH View Suite: A mobile-enabled platform that equips sales and marketing teams with instant access to critical intelligence on healthcare professionals and organizations, enhancing productivity and client engagement.
- Monocl Conferences: A specialized solution for life sciences organizations to optimize conference planning and participation, providing insights into key presentations, trending topics, and expert engagement opportunities.
Market Position and Competitive Landscape
Operating within the rapidly evolving healthcare data analytics industry, Definitive Healthcare stands out for its depth of data, innovative solutions, and focus on healthcare-specific use cases. Its competitors include companies like IQVIA and Truveta, but Definitive Healthcare differentiates itself through its tailored SaaS offerings and the integration of predictive analytics with real-time data visualization. The company's solutions address critical challenges faced by healthcare organizations, such as identifying high-growth markets, optimizing sales territories, and enhancing patient engagement strategies.
Revenue Model and Geographic Focus
Definitive Healthcare generates the majority of its revenue through subscription-based services, offering scalable solutions that cater to organizations of all sizes. While its primary market is the United States, the company also provides data on international healthcare providers, particularly in Canada, further broadening its client base and market reach.
Challenges and Opportunities
As a data-centric organization, Definitive Healthcare faces challenges such as ensuring the accuracy and comprehensiveness of its datasets, navigating complex regulatory environments, and mitigating cybersecurity risks. However, its investments in proprietary data science, AI-driven analytics, and user-friendly interfaces position it well to address these challenges and capitalize on growing demand for healthcare intelligence solutions.
Conclusion
Definitive Healthcare Corp. is a pivotal player in the healthcare commercial intelligence space, enabling organizations to unlock new opportunities and optimize their operations through data-driven insights. With its diverse product portfolio, deep industry expertise, and commitment to innovation, Definitive Healthcare continues to shape the future of the healthcare market, providing clients with the tools they need to succeed in an increasingly competitive landscape.
Definitive Healthcare Corp. (Nasdaq: DH) has announced its inclusion in the Russell 1000® Index, effective from December 20, 2021. This milestone aims to enhance the company's visibility to investors and broaden its shareholder base. CEO Jason Krantz expressed optimism about this change, stating it enables the introduction of healthcare commercial intelligence to a wider audience, helping businesses succeed in the complex healthcare market.
Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the Barclays Virtual Global Technology, Media and Telecommunications Conference on December 7, 2021, at 9:45 a.m. Eastern Time. The live presentation will be accessible via the investor relations page of Definitive Healthcare's website, with a limited-time replay available afterward. Definitive Healthcare specializes in healthcare commercial intelligence, providing a SaaS platform to help clients identify market opportunities and drive commercial success.
Definitive Healthcare Corp. (Nasdaq: DH) has successfully closed its underwritten public offering of 11 million shares of Class A common stock at $36.00 per share. Underwriters hold a 30-day option for an additional 1.65 million shares. Proceeds will fund acquisitions and general corporate purposes, including buying 7 million limited liability interests from AIDH TopCo, LLC, and repurchasing 2.23 million shares of its Class A stock. Goldman Sachs and J.P. Morgan led the offering with support from Morgan Stanley and Barclays.
Definitive Healthcare Corp. (Nasdaq: DH) announced a public offering of 11 million shares of its Class A common stock at $36.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 1.65 million shares. Closing is anticipated on November 22, 2021. Proceeds will fund acquisitions and general corporate purposes, such as buying 7 million limited liability interests from its subsidiary and repurchasing 2.23 million Class A shares. The offering is managed by Goldman Sachs & Co. and J.P. Morgan among others.
Definitive Healthcare Corp. (Nasdaq: DH) has initiated a public offering of 11,000,000 shares of its Class A common stock, with an option for underwriters to acquire an additional 1,650,000 shares. The net proceeds will fund acquisitions and general corporate purposes, including purchasing up to 7,000,000 limited liability interests from its subsidiary, AIDH TopCo, LLC, and repurchasing up to 2,233,238 shares of Class A stock. The offering is managed by leading financial firms, with a prospectus available through the SEC.
Definitive Healthcare Corp. (Nasdaq: DH) reported a strong Q3 2021, with revenue of $43.1 million, up 43% year-over-year. However, the company incurred a GAAP net loss of $(21.0) million, a significant rise from $(10.0) million in Q3 2020. Adjusted net income fell to $2.2 million compared to $5.1 million in the same quarter last year. The company forecasted Q4 2021 revenue between $44 million and $45 million, expecting a 32% year-over-year increase. Despite the losses, customer growth surged by 49%, reaching 377 clients with $100,000 or greater in annual recurring revenue.
Definitive Healthcare has integrated extensive Asian data sources into Monocl ExpertInsight, enhancing its platform with over 11 million worldwide expert profiles, focusing on the Chinese and Japanese healthcare markets. This expansion responds to customer demand for deeper insights in the APAC region, facilitating better expert identification and engagement strategies. The update includes local language capabilities, aiding medical professionals in understanding local experiences and exploring new scientific activities. This move aims to strengthen relationships and expand market presence in Asia-Pacific.
Definitive Healthcare Corp. (Nasdaq: DH) will release its third quarter financial results on November 8, 2021, after market close. A conference call is scheduled for 5:00 PM ET to discuss the results. Investors can access a live audio webcast on Definitive Healthcare’s Investor Relations website and dial in via provided numbers. The call will also be available for replay until November 22, 2021. Definitive Healthcare focuses on providing data and analytics to enhance commercial success in the healthcare sector.
Definitive Healthcare (Nasdaq: DH) has launched Latitude Reporting, a product that enables real-time custom patient cohort analysis targeting specific disease states. The tool allows life sciences companies to swiftly analyze extensive medical and prescription claims data, enhancing their go-to-market strategies. Users can create and adjust patient cohorts, gaining insights from billions of claims to support informed commercial decisions. Latitude Reporting aims to streamline healthcare data utilization, catering to various roles within the industry.
Definitive Healthcare (Nasdaq: DH) has appointed Robert Musslewhite as President, enhancing its Executive Leadership Team during a period of rapid growth. Musslewhite brings extensive healthcare experience, previously leading OptumInsight and serving on Definitive Healthcare's board. With a total addressable market exceeding $10 billion and a unique SaaS platform, the company is set for significant impact in the healthcare industry. His expertise is expected to drive the development of new commercial intelligence solutions.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
What does Definitive Healthcare Corp. do?
What industries does Definitive Healthcare serve?
How does Definitive Healthcare generate revenue?
What are some of Definitive Healthcare's key products?
What makes Definitive Healthcare unique in its industry?
Who are Definitive Healthcare's competitors?
What challenges does Definitive Healthcare face?
What geographic regions does Definitive Healthcare cover?
What is Monocl ExpertInsight?
How does Population Intelligence benefit businesses?
